Dr. Balzer is an accomplished international healthcare professional with extensive experience in Clinical Drug Development and Medical Affairs. In his most recent position, Dr. Balzer was Head of Clinical Development at Thrive Detect, an Exact Sciences Company, and was leading the development of a multi-cancer detection liquid biopsy assay.

Dr. Balzer worked for more than 25 years in various positions at Bayer HealthCare and served as Vice President and Global Head of Medical Affairs & Clinical Development Radiology at Bayer U.S. in NJ with responsibility for Bayer’s medical imaging business. This included pharmaceuticals (contrast media), medical devices, and informatics/ AI projects. Dr. Balzer also built, developed, and managed teams at different locations worldwide and completed four global clinical development programs/ NDAs as well as several additional indication expansions, which were all successful in achieving approval.

Dr. Balzer attended medical school in Berlin, Germany, and conducted his residency at the Benjamin Franklin Hospital of the Free University Berlin. He is board-certified in Germany in Internal Medicine, and he earned his Ph.D. from the Free University for work in neuro-endocrine pharmacology.

Dr. Balzer’s scientific work has been published in more than 60 peer-reviewed articles and several book chapters.